UNM Unum Group
Unum Group, together with its subsidiaries, provides financial protection benefit solutions in the United States, the United Kingdom, and Poland. It operates through Unum US, Unum International, Colonial Life, and Closed Block segments. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as voluntary benefits, individual disability, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products. It also provides group pensions, individual life and corporate-owned life insurance, reinsurance pools and management operations, and other miscellaneous products. The company sells its products to employers for the benefit of employees. It sells its products through field sales personnel, independent brokers, consultants, and independent contractor agent sales force and brokers. Unum Group was formerly known as UnumProvident Corporation and changed its name to Unum Group in March 2007. The company was founded in 1848 and is based in Chattanooga, Tennessee.…
Industry Peers
Insurance - LifeKey Statistics
About Unum Group (NYSE: UNM)
›
Unum Group (NYSE: UNM) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Insurance - Life industry, part of the Financial Services sector, and reports about 10,684 employees.
The shares were at 77.04 USD on 19 November 2026, up 1.3% over 52 weeks. Its 52-week range is 69.02 USD to 96.77 USD: the price is 20.4% below the high and 11.6% above the low.
At a market capitalisation of 11.94B USD, it trades at 52.4 times trailing earnings and 8.8 times forward earnings. The median trailing P/E of its 19 largest Insurance - Life peers is 11.4, a premium of 359% for UNM. It pays a dividend yielding 2.64% (it pays out 128% of its earnings), against a median of 2.72% among the dividend payers in that peer group.
Unum Group reports return on equity of 6.6%, an operating margin of 4.1% and revenue down 24.6% year over year.
Its debt exceeds its cash by 2.19B USD, a debt-to-equity ratio of 0.34. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 13 analysts cover the stock, with an average rating of Buy; their mean price target of 96.69 USD is 25.5% above the current price. The next earnings report is expected on 2 February 2027.